SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001387131-17-003298
Filing Date
2017-06-16
Accepted
2017-06-16 14:48:25
Documents
2
Group Members
BIOTEST PHARMACEUTICALS CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP bio-sc13d_060617.htm SC 13D 59426
2 STOCKHOLDERS AGREEMENT ex99-1.htm EX-99.1 254806
  Complete submission text file 0001387131-17-003298.txt   315871
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82025 | Film No.: 17915791
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address LANDSTEINERSTR. 5 DREIEICH 2M 63303
Business Address LANDSTEINERSTR. 5 DREIEICH 2M 63303 45 6103 801 225
Biotest AG (Filed by) CIK: 0001709152 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D